The Translational Pulmonary and Immunology Research Center (EIN: 47-2364652) is a nonprofit organization dedicated to fostering collaboration among specialists in the rare disease community, specifically focusing on conditions such as adult cystic fibrosis, food allergies, bronchiectasis, immune deficiency, and airway inflammatory disorders. With an operating budget of $13.3 million and total revenue of $11.4 million for the 2024 filing year, the center aims to create a more efficient research environment for clinical physician researchers, scientists, and advocates. The organization does not rely on a single funder for 50% or more of its revenue and can be found online at www.tpric.org.